Did Hedge Funds Drop The Ball On bluebird bio Inc (BLUE) ?
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why......(read more)
Posts Tagged ‘NASDAQ:BLUE’
Is bluebird bio Inc (BLUE) A Good Stock To Buy?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard since the end of the third quarter. NASDAQ and Russell......(read more)
Hedge Fund and Insider Trading News: Brevan Howard Asset Management, EJF Capital, David Einhorn, CoreSite Realty Corp (COR), Caesars Entertainment Co. (CZR), Restoration Robotics Inc (HAIR), and More
Brevan Howard Cuts Office Perks in London Headquarters (Bloomberg) Brevan Howard Asset Management, the hedge fund manager run by billionaire Alan Howard......(read more)
Five Stocks To Buy According To Top Biotech-Focused Funds
Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value......(read more)
bluebird bio Inc (BLUE), Iqvia Holdings Inc (IQV): Four Biotech Stocks to Buy Now
Healthcare sector has proven itself to be one of the most resilient sectors of the US economy. Since healthcare cannot be outsourced and represents an......(read more)
Here’s What’s So Important About The bluebird bio Inc (BLUE) Data
bluebird bio Inc (NASDAQ:BLUE) is up sharply pre market on Thursday, as the company put out fresh interim data from a phase I study of its multiple myeloma......(read more)
Is bluebird bio Inc (BLUE) A Good Stock To Buy?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating......(read more)
Cupps Capital Slashes Portfolio in Q3, But Couldn’t Stop Buying These 5 Stocks
Drew Cupps‘ Chicago-based asset management firm, Cupps Capital Management, has been in the news of late after it announced that its five-member......(read more)
Spark Therapeutics Inc (ONCE) and Other Profitable Healthcare Picks of Casdin Capital
At Insider Monkey, we track some 750 hedge funds and other institutional investors. We analyze their 13F filings and determine stocks that they are collectively......(read more)
This Biotech Hedge Fund’s Stock Picks Killed It in Q3
Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again. Hedge fund investors have been withdrawing their capital......(read more)
What is Going On With These 4 Plunging Stocks?
Shares of Freeport-McMoRan Inc (NYSE:FCX), Qiagen NV (NASDAQ:QGEN), McKesson Corporation (NYSE:MCK), and bluebird bio Inc (NASDAQ:BLUE) are deep in the......(read more)
Why Are Investors Heading For The Exits In These Five Stocks Today?
In yet another volatile trading session, the S&P 500 is off by more than 0.8% and the NASDAQ is down by 0.84% as investors weigh the negative implications......(read more)
Hedge Funds Aren’t Crazy About bluebird bio Inc (BLUE) Anymore
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors......(read more)
bluebird bio Inc (BLUE), Nektar Therapeutics (NKTR) Among Billionaire Stan Druckenmiller’s Top Small-Cap Picks
Stan Druckenmiller’s Duquesne Family Office LLC, previously Duquesne Capital, has filed its 13F for the reporting period of March 31. Druckenmiller......(read more)
Biogen Idec Inc (BIIB), Celgene Corporation (CELG), bluebird bio Inc (BLUE): Stanley Druckenmiller Bets on Biotech and Wins
In the last couple of years, biotechnology industry has been a hot topic and investors have been watching closely as the industry gained on average 40......(read more)
Druckenmiller, Buffett At Odds On International Business Machines Corp. (IBM): What Do Hedge Funds Think? Plus Druckenmiller’s Top New Picks
Duquesne Capital’s Stanley Druckenmiller respects Warren Buffett’s opinion on International Business Machines Corp. (NYSE:IBM); he just doesn’t......(read more)
Gilead Sciences (GILD), AstraZeneca (AZN), Bellicum Pharmaceuticals (BLCM): Redmile Group’s Top New Picks
Jeremy Green’s Redmile Group entered several new positions last quarter, as revealed by the 13F Form it filed with the U.S. Securities and Exchange......(read more)
